Vancomycin Area Under the Curve Dosing and Monitoring at an Academic Medical Center: Transition Strategies and Lessons Learned.

acute kidney injury area under the curve therapeutic drug monitoring vancomycin

Journal

Journal of pharmacy practice
ISSN: 1531-1937
Titre abrégé: J Pharm Pract
Pays: United States
ID NLM: 8900945

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 12 3 2019
medline: 24 4 2021
entrez: 12 3 2019
Statut: ppublish

Résumé

Due to the inconsistent correlation of vancomycin trough concentrations with 24-hour area under the curve (AUC) and a desire to reduce rates of vancomycin-associated acute kidney injury, an institutional guideline was implemented by the Antimicrobial Stewardship Team in September 2017 to monitor vancomycin using AUC. Three stages were utilized to organize the process: preparation, implementation, and evaluation. The preparation stage was used to present literature to key stakeholders, and pharmacy meetings focused on the development of a dosing and monitoring guideline. Along with institution-wide education, the implementation stage included information technology development and support. The evaluation stage was comprised of quality improvement and clinical research. Future plans include dissemination of the results and analyses. Numerous lessons were learned due to barriers experienced during the process, but the transition was successful.

Identifiants

pubmed: 30852937
doi: 10.1177/0897190019834369
doi:

Substances chimiques

Anti-Bacterial Agents 0
Vancomycin 6Q205EH1VU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

774-778

Auteurs

Eric R Gregory (ER)

Department of Pharmacy Services, 12251The University of Kansas Health System, Kansas City, KS, USA.

Donna R Burgess (DR)

Department of Pharmacy Services, UK HealthCare, Lexington, KY, USA.
Department of Pharmacy Practice and Science, 4530University of Kentucky College of Pharmacy, Lexington, KY, USA.

Sarah E Cotner (SE)

Department of Pharmacy Services, UK HealthCare, Lexington, KY, USA.
Department of Pharmacy Practice and Science, 4530University of Kentucky College of Pharmacy, Lexington, KY, USA.

Jeremy D VanHoose (JD)

Department of Pharmacy Services, UK HealthCare, Lexington, KY, USA.

Alexander H Flannery (AH)

Department of Pharmacy Services, UK HealthCare, Lexington, KY, USA.
Department of Pharmacy Practice and Science, 4530University of Kentucky College of Pharmacy, Lexington, KY, USA.

Brian Gardner (B)

Department of Pharmacy Services, UK HealthCare, Lexington, KY, USA.
Department of Pharmacy Practice and Science, 4530University of Kentucky College of Pharmacy, Lexington, KY, USA.

Elizabeth B Autry (EB)

Department of Pharmacy Services, UK HealthCare, Lexington, KY, USA.
Department of Pharmacy Practice and Science, 4530University of Kentucky College of Pharmacy, Lexington, KY, USA.

Derek W Forster (DW)

Division of Infectious Diseases, Department of Internal Medicine, 4530University of Kentucky College of Medicine, Lexington, KY, USA.

David S Burgess (DS)

Department of Pharmacy Practice and Science, 4530University of Kentucky College of Pharmacy, Lexington, KY, USA.

Katie L Wallace (KL)

Department of Pharmacy Services, UK HealthCare, Lexington, KY, USA.
Department of Pharmacy Practice and Science, 4530University of Kentucky College of Pharmacy, Lexington, KY, USA.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Humans China Cerebral Hemorrhage Patient Care Bundles Length of Stay

Classifications MeSH